Navigation Links
Krishagni Enables University of New South Wales (Australia) to Adopt caTissue Plus
Date:1/17/2013

(PRWEB) January 17, 2013

Krishagni Solutions today announces collaboration with Translational Cancer Research Network (TCRN) of the University of New South Wales (UNSW), Sydney, Australia to adopt the caTissue Plus Application.

caTissue is a biospecimen management tool developed as part of the caBIG® program, a National Cancer Institute (NCI) initiative. caTissue accelerates research discoveries and improves patient outcomes by linking researchers, physicians, and patients throughout the cancer community. caTissue Plus is an Open Source initiative of Krishagni Solutions to enhance NCI’s version of caTissue with new features, usability and performance enhancements.

In addition to providing support to the TCRN for the adoption of caTissue Plus, Krishagni will also provide ongoing SLA based support for next three years; integrate caTissue Plus with their pathology information system, digital pathology imaging information system, and data migration of two legacy databases. “Krishagni is an integral to the deployment of caTissue Plus at TCRN. Krishagni’s intimate knowledge of caTissue and biobanking domain makes them most suited," said Information Manager, Translational Cancer Research Network UNSW.

Krishagni is an offshore software product development and services company focused on informatics for clinical research based in India. “Many members of our team have been involved in the development of caTissue since 2005. Our team has intimate knowledge of the caTissue product and its technology is based on our active involvement in providing support on the NCI Forums to the caTissue community," said Mr Srikanth Adiga, CEO and Founder of Krishagni. "The first version of caTissue Plus has been adopted in Washington University and is under evaluation in other centres. The adoption at UNSW further confirms the need for such an initiative. We will continue to invest in caTissue with Plus v2.0 being available in Nov/2012 and Plus v3.0 scheduled to be released in early 2013."

For more information on caTissue Services at Krishagni, visit: http://www.catissueplus.org.

About Krishagni:
Krishagni is a software product development and services company with sole focus on Informatics Clinical Research. Our focus on open source based solutions and vast experience in working with academic institutes for past 10+ years, makes us an ideal partner for Clinical Informatics development needs. Our expertise includes web and mobile application development, data warehousing and mining, natural language processing, ETL, system integration (HL7, web services, ESB), and so forth. Our current clients include Washington University, Johns Hopkins, University of Leicester, BRISSKit (U.K.), University of New South Wales, and Univ of Utah.

About TCRN, UNSW:

The TCRN – a translational cancer research program funded by the Cancer Institute NSW – comprises the founding institutions of the University of New South Wales, Prince of Wales Hospital, comprehensive cancer centres at St George and Sutherland hospitals, cancer services at the Royal Hospital for Women, Border Medical Oncology Research Unit, and the University of Technology, Sydney. Biobanking is one of our major initiatives and a core component of this has been establishing the TCRN’s biobank, which is known HSA Biobank, hosted by the Lowy Biorepository at UNSW. One of the aims of HSA Biobank is to provide a streamlined process for the universal collection of biospecimens with linked clinical data from consenting cancer patients undergoing treatment and diagnosis.

For more information, visit: http://www.tcrn.unsw.edu.au , http://www.biorepository.unsw.edu.au

Read the full story at http://www.prweb.com/releases/krishagni/catissue/prweb10220913.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Powerful AAC Device With Intel® i7 Processor Enables Natural Communication for Stroke, ALS and Autism Patients
2. Magnetic actuation enables nanoscale thermal analysis
3. New portable device enables RNA detection from ultra-small sample in only 20 minutes
4. Arizona State University engineers aim to improve performance of technology in extreme environments
5. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
6. Causes of Gulf War Illness are complex and vary by deployment area -- Baylor University study
7. HistoRx Licenses Melanoma Assay from Yale University
8. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
9. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
10. Research at Rice University leads to nanotube-based device for communication, security, sensing
11. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):